Answers are grounded in this paper and cite their sources.
Unsupervised hierarchical clustering of early-stage breast cancer glycogene expression data using the Growing Hierarchical Self Organising Representation Map (GHSORM) algorithm identified seven subclasses. These glycogene expression clusters (GECs) overlap with known breast cancer biomarkers such as hormone receptor status and immune signatures. Feature discovery via Recursive Feature Elimination with Strikeout (RFES) identified a panel of 60 glycogenes that can predict GECs on an independent testing set with 90.48% accuracy. GEC-based subtyping of patients from the I-SPY2 clinical trial revealed an 86% pathologic complete response (pCR), demonstrating how glycogene expression in combination with custom machine learning algorithms could be an approach to molecular cancer diagnosis capable of informing personalised drug treatment.
No takes yet. Share an insight, caveat, or question.
Venter et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: